{
  "cik": "0001919246",
  "name": "Pelthos Therapeutics Inc.",
  "entityType": "operating",
  "sic": "2836",
  "sicDescription": "Biological Products, (No Diagnostic Substances)",
  "stateOfIncorporation": "NV",
  "stateOfIncorporationDescription": "NV",
  "fiscalYearEnd": "1231",
  "tickers": [
    "PTHS"
  ],
  "exchanges": [
    "NYSE"
  ],
  "ein": "863335449",
  "description": "",
  "website": "",
  "investorWebsite": "",
  "category": "<br>Emerging growth company",
  "phone": "919-908-2422",
  "flags": "",
  "formerNames": [
    {
      "name": "Channel Therapeutics Corp",
      "from": "2024-11-18T05:00:00.000Z",
      "to": "2025-05-27T04:00:00.000Z"
    },
    {
      "name": "Chromocell Therapeutics Corp",
      "from": "2022-09-06T04:00:00.000Z",
      "to": "2024-11-15T05:00:00.000Z"
    }
  ],
  "filings_count": 164,
  "download_timestamp": "2025-08-02 07:29:30 UTC"
}